Figure 1
Study population flow chart. EGV esophageal or gastric varices, CLD chronic liver disease, PHTN portal hypertension, DILI drug induced liver injury, PSC primary sclerosing cholangitis, NRH nodular regenerative hyperplasia.
Figure 1 | Scientific Reports
